Antibody to hepatitis B [imft]    
Surface [spco]    
Increase [ftcn]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
Chronic infection [dsyn]    
Hepatitis B Virus [virs]    
Retrospective Cohort Study [resa]    
Simultaneous [tmco]    
detect [topp]    
Antibody to hepatitis B [imft]    
Surface [spco]    
Unusual [qlco]    
Chronic infection [dsyn]    
Hepatitis B Virus [virs]    
Relate [orch]    
More [ftcn]    
Advance [qlco]    
Liver disease [dsyn]    
This [euka]    
Retrospective Cohort Study [resa]    
Long-term [tmco]    
Aim [idcn]    
To [qlco]    
investigate [ftcn]    
Antibody to hepatitis B [imft]    
Surface [spco]    
Increase [ftcn]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
Chronic infection [dsyn]    
Hepatitis B Virus [virs]    
% total [qnco]    
1+ [qnco]    
{Non-patient} [clna]    
Hepatocellular carcinoma [neop]    
followed [tmco]    
median [spco]    
year [tmco]    
Ranges [qnco]    
year [tmco]    
Multivariate Analyses [qnco]    
Perform [ftcn]    
To [qlco]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Prevalence [qnco]    
Antibody to hepatitis B [imft]    
Surface [spco]    
univariate analysis [resa]    
>5 [qnco]    
year [tmco]    
Cumulative [qlco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
High [qlco]    
Group [idcn]    
Only [qnco]    
Group [idcn]    
23 [qnco]    
69 [inpr]    
Multivariate Analysis [qnco]    
Antibody to hepatitis B [imft]    
Surface [spco]    
Hazard Ratio [qnco]    
+2 [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
Male gender [fndg]    
Hazard Ratio [qnco]    
1+ [qnco]    
Confidence Interval [qnco]    
31 [inpr]    
0.018" [qnco]    
Age [orga]    
/40 [tmco]    
year [tmco]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
Cirrhosis [dsyn]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
Identifiable [qlco]    
Independence [idcn]    
Factor [ftcn]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Cumulative [qlco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
Increase [qnco]    
Proportion [qnco]    
*Number [qnco]    
Risk factor [qnco]    
Conclusion [idcn]    
Antibody to hepatitis B [imft]    
Surface [spco]    
Increase [ftcn]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Chronic infection [dsyn]    
Hepatitis B Virus [virs]    
consideration [fndg]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Required [ftcn]    
patient [podg]    
Antibody to hepatitis B [imft]    
Surface [spco]    
virol [lipd]    
[c] [qnco]    
